Lv3
210 积分 2021-03-03 加入
Dapagliflozin in Patients with Chronic Kidney Disease
4天前
已完结
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
4天前
已完结
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
4天前
已完结
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
4天前
已完结
Association Between Cigarette Smoking and Subclinical Markers of Cardiovascular Harm
7天前
已完结
Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease
8天前
已完结
Heart Failure with Preserved Ejection Fraction
10天前
已完结
Elevated NT-proBNP in Heart Failure and CKD
16天前
已完结
External Validation of the American Heart Association PREVENT Cardiovascular Disease Risk Equations
17天前
已完结
Impact of Multimorbidity on Mortality in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
23天前
已完结
皖公网安备34019202002308
